GE HealthCare Technologies Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
GE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These off...
Latest News
1 day ago · gurufocus.com
GE HealthCare debuts Allia Celeo, a ceiling-mounted interventional system designed for smooth procedural flow and AI-powered precision imagingGE HealthCare (Nasdaq: GEHC) today introduced Allia⢠Celeo,* a ceiling-mounted image guiding system, at the Transcatheter Cardiovascular Therapeutics (TCT) 20
4 days ago · zacks.com
GEHC vs. HAE: Which Stock Is the Better Value Option?Investors with an interest in Medical - Products stocks have likely encountered both GE HealthCare Technologies (GEHC) and Haemonetics (HAE). But which of these two stocks is more attractive to value investors?
4 days ago · seekingalpha.com
GE HealthCare: Broad-Based Growth Makes The Bull Case More CompellingGE HealthCare Technologies delivered strong 3Q26 results, with broad-based demand, 6.2% organic revenue growth, and meaningful margin expansion. Pharmaceutical Diagnostics and Flyrcado offer attractive growth, while the SOFIE acquisition should strengthen radiopharmaceutical capabilities and future revenue streams. Raised 2026 outlook: organic revenue growth to 4%, adjusted EPS to $4.95–$5.05, and free cash flow to at least $1.6 billion.
4 days ago · marketbeat.com
GE HealthCare Technologies Q3 Earnings Call HighlightsGE HealthCare Technologies NASDAQ: GEHC reported third-quarter 2026 revenue growth across all of its business segments, supported by demand in imaging and pharmaceutical diagnostics, improved execution in patient care products and margin expansion.
5 days ago · benzinga.com
GE HealthCare Lifts Forecasts on Healthy Hospital SpendingGE HealthCare Technologies Inc. (NASDAQ:GEHC) shares rose Wednesday after the company reported third-quarter results that topped Wall Street estimates.
5 days ago · seekingalpha.com
GE HealthCare Technologies Inc. (GEHC) Q3 2026 Earnings Call TranscriptGE HealthCare Technologies Inc. (GEHC) Q3 2026 Earnings Call Transcript
5 days ago · zacks.com
GEHC Q3 Earnings Beat Estimates on Strong Growth, '26 View RaisedGE HealthCare's Q3 earnings and revenues beat estimates on strong segment growth and higher margins, driving raised 2026 guidance as shares gain 8.3%.
5 days ago · zacks.com
Compared to Estimates, GE HealthCare (GEHC) Q3 Earnings: A Look at Key MetricsWhile the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
5 days ago · zacks.com
GE HealthCare Technologies (GEHC) Q3 Earnings and Revenues Beat EstimatesGE HealthCare Technologies (GEHC) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.21 per share. This compares to earnings of $1.07 per share a year ago.
5 days ago · businesswire.com
GE HealthCare reports third quarter 2026 financial resultsCHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today reported financial results for the third quarter ended September 30, 2026. GE HealthCare President and CEO Peter Arduini said, “We delivered strong top-line growth and margin expansion across all segments, and robust EPS growth in the third quarter. This reflects our teams' commercial execution, disciplined operational focus enabled by Heartbeat, and continued customer adoption of our innovations. With our improved performance year-to.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove GEHC